WebbFind the latest dividend history for Prothena Corporation plc Ordinary Shares (PRTA) ... Corporate Services COVID-19 Center; ... Price/Earnings Ratio is a widely used stock evaluation measure. WebbBased on 7 analysts offering 12 month price targets for Prothena Corp Public Ltd Co. Min Forecast. $50.00 +3.58%. Avg Forecast. $79.14 +63.96%. Max Forecast. $110.00 …

Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary

WebbFör 1 dag sedan · DEERFIELD, Ill. & DUBLIN, April 13, 2024--Walgreens and Prothena today announced a collaboration to accelerate patient identification and recruitment for Prothena’s ongoing ASCENT-2 multiple ... WebbProthena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. inhalt pyramus und thisbe

Prothena (NASDAQ:PRTA) Stock Crosses Below 200-Day Moving …

WebbPRTA Stock Summary With a price/sales ratio of 47.31, PROTHENA CORP PUBLIC LTD CO has a higher such ratio than 96.35% of stocks in our set. With a year-over-year growth in … WebbOptions Prices. Barchart allows you to view options by Expiration Date (select the expiration month/year using the drop-down menu at the top of the page). Weekly expiration dates are labeled with a (w) in the expiration date list. Options information is delayed a minimum of 15 minutes, and is updated at least once every 15-minutes through-out ... WebbProthena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced new... PRTA : 48.47 (+1.70%) Prothena to Participate in Stifel 2024 Virtual CNS Days Business Wire - Tue Mar 21, 3:05PM CDT mke to ord bus